Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 4532320, 7 pages
https://doi.org/10.1155/2017/4532320
Research Article

Impact of Fatty Liver on Acute Pancreatitis Severity

1Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
3Department of Radiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
4Center for Cancer Prevention and Detection, National Cancer Center, Goyang-si, Republic of Korea

Correspondence should be addressed to In Seok Lee; rk.ca.cilohtac@elsi

Received 24 December 2016; Accepted 22 March 2017; Published 27 April 2017

Academic Editor: Alessandro Zerbi

Copyright © 2017 Seung Bae Yoon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Yadav and A. B. Lowenfels, “The epidemiology of pancreatitis and pancreatic cancer,” Gastroenterology, vol. 144, no. 6, pp. 1252–1261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. S. Swaroop, S. T. Chari, and J. E. Clain, “Severe acute pancreatitis,” Jama, vol. 291, no. 23, pp. 2865–2868, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Banks, M. L. Freeman, and G Practice Parameters Committee of the American College of, “Practice guidelines in acute pancreatitis,” The American Journal of Gastroenterology, vol. 101, no. 10, pp. 2379–2400, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Whitcomb, “Clinical practice. Acute pancreatitis,” The New England Journal of Medicine, vol. 354, no. 20, pp. 2142–2150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Larvin and M. J. McMahon, “APACHE-II score for assessment and monitoring of acute pancreatitis,” Lancet, vol. 2, no. 8656, pp. 201–205, 1989. View at Google Scholar
  6. J. H. Ranson and B. S. Pasternack, “Statistical methods for quantifying the severity of clinical acute pancreatitis,” The Journal of Surgical Research, vol. 22, no. 2, pp. 79–91, 1977. View at Publisher · View at Google Scholar · View at Scopus
  7. I. A. Al Mofleh, “Severe acute pancreatitis: pathogenetic aspects and prognostic factors,” World Journal of Gastroenterology, vol. 14, no. 5, pp. 675–684, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Yang, J. Chen, A. R. Phillips, J. A. Windsor, and M. S. Petrov, “Predictors of severe and critical acute pancreatitis: a systematic review,” Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 46, no. 5, pp. 446–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. A. Banks, T. L. Bollen, C. Dervenis et al., “Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus,” Gut, vol. 62, no. 1, pp. 102–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. F. Thoeni, “The revised Atlanta classification of acute pancreatitis: its importance for the radiologist and its effect on treatment,” Radiology, vol. 262, no. 3, pp. 751–764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Balthazar, J. H. Ranson, D. P. Naidich, A. J. Megibow, R. Caccavale, and M. M. Cooper, “Acute pancreatitis: prognostic value of CT,” Radiology, vol. 156, no. 3, pp. 767–772, 1985. View at Publisher · View at Google Scholar
  12. K. J. Mortele, W. Wiesner, L. Intriere et al., “A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome,” AJR American Journal of Roentgenology, vol. 183, no. 5, pp. 1261–1265, 2004. View at Publisher · View at Google Scholar
  13. T. L. Bollen, V. K. Singh, R. Maurer et al., “A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis,” The American Journal of Gastroenterology, vol. 107, no. 4, pp. 612–619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. K. Reddy, M. Zhan, H. R. Alexander, and S. S. El-Kamary, “Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders,” World Journal of Gastroenterology, vol. 19, no. 45, pp. 8301–8311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Limanond, S. S. Raman, C. Lassman et al., “Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings,” Radiology, vol. 230, no. 1, pp. 276–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. C. Marshall, D. J. Cook, N. V. Christou, G. R. Bernard, C. L. Sprung, and W. J. Sibbald, “Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome,” Critical Care Medicine, vol. 23, no. 10, pp. 1638–1652, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Kodama, C. S. Ng, T. T. Wu et al., “Comparison of CT methods for determining the fat content of the liver,” AJR American Journal of Roentgenology, vol. 188, no. 5, pp. 1307–1312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Boyce, P. J. Pickhardt, D. H. Kim et al., “Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT,” AJR American Journal of Roentgenology, vol. 194, no. 3, pp. 623–628, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I. R. Wanless and J. S. Lentz, “Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors,” Hepatology, vol. 12, no. 5, pp. 1106–1110, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. M. R. Teli, C. P. Day, A. D. Burt, M. K. Bennett, and O. F. James, “Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver,” Lancet, vol. 346, no. 8981, pp. 987–990, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Vernon, A. Baranova, and Z. M. Younossi, “Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults,” Alimentary Pharmacology & Therapeutics, vol. 34, no. 3, pp. 274–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Angulo, “Nonalcoholic fatty liver disease - reply,” New England Journal of Medicine, vol. 347, no. 10, pp. 769–769, 2002. View at Google Scholar
  23. J. G. Fan, “Epidemiology of alcoholic and nonalcoholic fatty liver disease in China,” Journal of Gastroenterology and Hepatology, vol. 28, Supplement 1, pp. 11–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. G. Fan and G. C. Farrell, “Epidemiology of non-alcoholic fatty liver disease in China,” Journal of Hepatology, vol. 50, no. 1, pp. 204–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. X. Cao and J. G. Fan, “Editorial: Fatty liver disease: a growing public health problem worldwide,” Journal of Digestive Diseases, vol. 12, no. 1, pp. 1–2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Chalasani, Z. Younossi, J. E. Lavine et al., “The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association,” Hepatology, vol. 55, no. 6, pp. 2005–2023, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. E. Baumeister, H. Völzke, P. Marschall et al., “Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation,” Gastroenterology, vol. 134, no. 1, pp. 85–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Oruc, O. Ozutemiz, G. Yuce et al., “Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study,” BMC Gastroenterology, vol. 9, no. 1, p. 16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Yoneda, H. Mawatari, K. Fujita et al., “High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH,” Journal of Gastroenterology, vol. 42, no. 7, pp. 573–582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. Wang, J. Du, P. Yu et al., “Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis,” Scientific Reports, vol. 5, p. 17833, 2015. View at Publisher · View at Google Scholar · View at Scopus